Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel preparation method for N6-Bz-A-S-GNA phosphoramidite ensures high purity and scalability. Cost-effective solution for oligonucleotide manufacturing supply chains.
Patent CN108047139B details a novel synthesis route for chalcone-benzimidazole salts, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel purification method for Crisaborole reduces impurities below 0.05% and simplifies solvent usage, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel room-temperature acid hydrolysis of scutellarin yields high-purity scutellarein without organic solvents, offering significant cost and supply chain advantages.
Novel Lewis acid catalyzed route offers high purity 2-aminoindan with reduced cost and enhanced safety for scalable pharmaceutical intermediate manufacturing supply chains.
Novel azide ring-opening route for Ticagrelor Intermediate C. Reduces steps, improves purity, ensures supply chain stability for API manufacturing.
Novel biocatalytic route for L-carnitine production offers >99% ee, reduced toxicity, and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN103044482A reveals a novel organotin anticancer agent with superior liposolubility. Discover cost-effective manufacturing routes for high-purity pharmaceutical intermediates.
Patent CN107556355A reveals novel AcO-MMT-Cl route for high-purity nucleoside phosphoramidites. Enhances supply chain reliability and reduces purification costs significantly.
Patent CN107176952A details a novel synthesis route for key pharmaceutical intermediates offering improved yield and supply chain stability for global procurement teams.
Discover the novel one-step Suzuki coupling route for 5-chloro-2-(pyridin-3-yl)pyridin-3-amine. High yield, scalable process for pharmaceutical intermediate manufacturing.
Advanced synthesis of AMN107 oxidative degradation impurity via patent CN107188887A. Ensures high-purity standards and cost reduction in pharmaceutical intermediate manufacturing.
Novel trifluorosulfonate catalyzed route for N-sulfonyl tetrahydro-beta-carboline derivatives. High yield, scalable process for pharmaceutical intermediate manufacturing.
Patent CN102432496A details an acidic recrystallization method for carbidopa, ensuring high purity and yield. Discover cost-effective manufacturing solutions.
Novel patent CN106083839B details a high-purity Dasatinib preparation method offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel oxidation method for Epinastine Impurity A ensures >95% purity. Cost-effective process for pharmaceutical quality control and supply chain stability.
Patent CN119176776A reveals a novel Lewis acid-catalyzed route for beta-lactamase inhibitor intermediates, offering high selectivity and simplified purification for reliable supply chains.
Patent CN102826985B details a high-yield 3-step synthesis for pharmaceutical intermediates. Discover cost-effective scaling and purity advantages for your supply chain.
Patent CN111217756B reveals a safer, scalable route for dexmedetomidine hydrochloride, eliminating high-risk hydrogenation and complex protection steps for reliable supply.
Advanced preparation of Relugolix Impurity I and II via novel condensation and cyclization. Enhances QC reliability and reduces API manufacturing costs significantly.